Elevated AVP levels have been associated with enhanced hepatic gluconeogenesis and glycogenolysis, contributing to hyperglycemia and the development of insulin resistance—both key drivers of hepatic lipid accumulation. This evidence concerns the gene AVP and Insulin resistance.